(KPT) KP Tissue - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA48265Y1043
KPT: Tissues, Towels, Napkins
KP Tissue Inc. (TO:KPT) is a leading manufacturer and distributor of disposable tissue products in North America, operating through its interest in Kruger Products L.P. The company serves both consumer and institutional markets, offering a diverse portfolio of products including bathroom and facial tissues, paper towels, and napkins. Its well-known brands such as Cashmere, SpongeTowels, and Scotties dominate retail shelves, while it also caters to the Away-From-Home segment with products like Embassy and Satinelle. In addition to its branded offerings, KP Tissue Inc. provides private label solutions, making it a key player in the tissue products industry. Headquartered in Mississauga, Canada, the company was established in 2012 and has since maintained a strong presence in both Canada and the United States.
From a technical standpoint, KPT has shown stability, with its SMA 20, 50, and 200 all hovering closely around its last price of 8.03. The ATR of 0.12 indicates low volatility, suggesting a stable trading range. The average 20-day volume of 14,415 reflects moderate liquidity.
Fundamentally, the companys market cap of 79.54M CAD positions it in the small-cap category. Its P/E ratio of 12.65 indicates reasonable valuation relative to earnings, while the forward P/E of 19.16 suggests expectations of future earnings growth. The P/B ratio of 1.11 points to a fair valuation relative to book value, and an RoE of 9.02 highlights moderate profitability.
Over the next three months, based on
Additional Sources for KPT Stock
KPT Stock Overview
Market Cap in USD | 56m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
KPT Stock Ratings
Growth 5y | 6.0% |
Fundamental | 13.0% |
Dividend | 67.0% |
Rel. Strength Industry | -7.42 |
Analysts | - |
Fair Price Momentum | 7.90 CAD |
Fair Price DCF | 8.09 CAD |
KPT Dividends
Dividend Yield 12m | 9.06% |
Yield on Cost 5y | 9.39% |
Annual Growth 5y | 0.00% |
Payout Consistency | 95.4% |
KPT Growth Ratios
Growth Correlation 3m | -37.1% |
Growth Correlation 12m | 11.9% |
Growth Correlation 5y | 8.9% |
CAGR 5y | 0.45% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | -0.25 |
Alpha | -3.11 |
Beta | 0.20 |
Volatility | 13.32% |
Current Volume | 16.6k |
Average Volume 20d | 16.7k |
As of March 12, 2025, the stock is trading at CAD 7.85 with a total of 16,569 shares traded.
Over the past week, the price has changed by -2.00%, over one month by +0.38%, over three months by -3.19% and over the past year by +2.61%.
Neither. Based on ValueRay Fundamental Analyses, KP Tissue is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.02 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KPT as of March 2025 is 7.90. This means that KPT is currently overvalued and has a potential downside of 0.64%.
KP Tissue has no consensus analysts rating.
According to ValueRays Forecast Model, KPT KP Tissue will be worth about 8.6 in March 2026. The stock is currently trading at 7.85. This means that the stock has a potential upside of +9.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 9 | 14.6% |
Analysts Target Price | - | - |
ValueRay Target Price | 8.6 | 9.3% |